Sanofi aims to cut AI-driven drug development timelines in half with Snowflake
Source: SiliconANGLE
2026-06-03 09:13:54 ET
The pharmaceutical industry’s research and development marathon — stretching 10 to 12 years from hypothesis to approval — is set to shrink as AI-driven drug development compresses that timeline. The shift from AI experimentation to real transformation of business workflows is accelerating across industries, but few examples carry higher stakes than pharma, where a drug’s […]
The post Sanofi aims to cut AI-driven drug development timelines in half with Snowflake appeared first on SiliconANGLE .
Snowflake Inc.
NASDAQ: SNOW
SNOW Trading
-2.53% G/L:
$238.84 Last:
4,298,075 Volume:
$242.20 Open:
SNOW Latest News
June 05, 2026 11:27:31 am
OpenGov and Snowflake build a knowledge graph to unify government data and AI
June 04, 2026 11:01:39 pm
Snowflake pushes interoperability-first vision as Apache Iceberg gains enterprise momentum
June 04, 2026 10:37:34 pm
As enterprise AI scales, Capital One and Snowflake focus on governance and trust
SNOW Stock Data
$62,793,700,000
318,930,400
2.49%
715
N/A
Software & IT Services
Technology
US
Bozeman
